The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party-Reference-Cited by-同舟云学术

The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party

Published:2019-01 Issue:1 Volume:25 Page:86-93
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kyriakou Charalampia,Boumendil Ariane,Finel Herve,NN Norbert Schmitz ,Andersen Niels Smedegaard,Blaise Didier,Chevallier Patrice,Browne Paul,Malladi Ram,Niederwieser Dietger,Pagliuca Antonio,Kroschinsky Frank,Montoto Silvia,Dreger Peter

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference45 articles.

1. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project;Sant;Blood,2010

2. Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry;van Kampen;J Clin Oncol,2011

3. Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial;Glass;Lancet Oncol,2014

4. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation;Fenske;Br J Haematol,2016

5. Reduced-intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: An analysis from the Lymphoma Working Party of the EBMT [e-pub ahead of print];Robinson;Ann Oncol,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT;Blood Advances;2024-07-26

2. HCT in Elderly Patients;The EBMT Handbook;2024

3. Feasibility of allogeneic hematopoietic stem cell transplantation in advanced age;Annals of Hematology;2023-11-04

4. Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study;Haematologica;2023-08-31

5. Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation;Annals of Hematology;2023-01-12